Protein Tyrosine Phosphatase µ (PTP µ or PTPRM), a Negative Regulator of Proliferation and Invasion of Breast Cancer Cells, is Associated with Disease Prognosis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Nov 28

PMID 23185569

Citations 25

Authors

Ping-Hui Sun

Lin Ye

Malcolm D Mason

Wen G Jiang

Affiliations

Soon will be listed here.

Abstract

Background: PTPRM has been shown to exhibit homophilic binding and confer cell-cell adhesion in cells including epithelial and cancer cells. The present study investigated the expression of PTPRM in breast cancer and the biological impact of PTPRM on breast cancer cells.

Design: Expression of PTPRM protein and gene transcript was examined in a cohort of breast cancer patients. Knockdown of PTPRM in breast cancer cells was performed using a specific anti-PTPRM transgene. The impact of PTPRM knockdown on breast cancer was evaluated using in vitro cell models.

Results: A significant decrease of PTPRM transcripts was seen in poorly differentiated and moderately differentiated tumours compared with well differentiated tumours. Patients with lower expression of PTPRM had shorter survival compared with those which had a higher level of PTPRM expression. Knockdown of PTPRM increased proliferation, adhesion, invasion and migration of breast cancer cells. Furthermore, knockdown of PTPRM in MDA-MB-231 cells resulted in increased cell migration and invasion via regulation of the tyrosine phosphorylation of ERK and JNK.

Conclusions: Decreased expression of PTPRM in breast cancer is correlated with poor prognosis and inversely correlated with disease free survival. PTPRM coordinated cell migration and invasion through the regulation of tyrosine phosphorylation of ERK and JNK.

Citing Articles

TMEM176B Promotes EMT via FGFR/JNK Signalling in Development and Tumourigenesis of Lung Adenocarcinoma.

Sun P, Xia S, Yuan R, Zhang B, Wang G Cancers (Basel). 2024; 16(13).

PMID: 39001509 PMC: 11240709. DOI: 10.3390/cancers16132447.

Cellular and clinical impact of protein phosphatase enzyme epigenetic silencing in multiple cancer tissues.

Wiltshire E, de Moura M, Pineyro D, Joshi R Hum Genomics. 2024; 18(1):24.

PMID: 38475971 PMC: 10935810. DOI: 10.1186/s40246-024-00592-x.

Genomic Analysis Reveals Candidate Genes Underlying Sex-Linked Eyelid Coloboma, Feather Color Traits, and Climatic Adaptation in Huoyan Geese.

Wen J, Yu J, Zhang L, Li H, Wang H, Gu H Animals (Basel). 2023; 13(23).

PMID: 38066959 PMC: 10705202. DOI: 10.3390/ani13233608.

Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathy.

Cohen C, De Blasio M, Farrugia G, Dona M, Hsu I, Prakoso D iScience. 2023; 26(10):107759.

PMID: 37736052 PMC: 10509303. DOI: 10.1016/j.isci.2023.107759.

Role of protein tyrosine phosphatase receptor type M in epithelial ovarian cancer progression.

Li X, Ding W, Rao Y, Qu P J Ovarian Res. 2023; 16(1):131.

PMID: 37403117 PMC: 10318840. DOI: 10.1186/s13048-023-01220-3.

References

Jiang W, Hiscox S, Hallett M, Horrobin D, Mansel R, Puntis M . Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA). Cancer Res. 1995; 55(21):5043-8. View

Hiscox S, Jiang W . Association of PTPmu with catenins in cancer cells: a possible role for E-cadherin. Int J Oncol. 1998; 13(5):1077-80. DOI: 10.3892/ijo.13.5.1077. View

Cully M, You H, Levine A, Mak T . Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer. 2006; 6(3):184-92. DOI: 10.1038/nrc1819. View

Brady-Kalnay S, Flint A, Tonks N . Homophilic binding of PTP mu, a receptor-type protein tyrosine phosphatase, can mediate cell-cell aggregation. J Cell Biol. 1993; 122(4):961-72. PMC: 2119586. DOI: 10.1083/jcb.122.4.961. View

Tartaglia M, Gelb B . Germ-line and somatic PTPN11 mutations in human disease. Eur J Med Genet. 2005; 48(2):81-96. DOI: 10.1016/j.ejmg.2005.03.001. View

Angers-Loustau A, Cote J, Tremblay M . Roles of protein tyrosine phosphatases in cell migration and adhesion. Biochem Cell Biol. 2000; 77(6):493-505. View

Giefing M, Zemke N, Brauze D, Kostrzewska-Poczekaj M, Luczak M, Szaumkessel M . High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma. Genes Chromosomes Cancer. 2011; 50(3):154-66. DOI: 10.1002/gcc.20840. View

Stoker A . Protein tyrosine phosphatases and signalling. J Endocrinol. 2005; 185(1):19-33. DOI: 10.1677/joe.1.06069. View

Hellberg C, Burden-Gulley S, Pietz G, Brady-Kalnay S . Expression of the receptor protein-tyrosine phosphatase, PTPmu, restores E-cadherin-dependent adhesion in human prostate carcinoma cells. J Biol Chem. 2002; 277(13):11165-73. DOI: 10.1074/jbc.M112157200. View

10.

Stambolic V, Suzuki A, de la Pompa J, Brothers G, Mirtsos C, Sasaki T . Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998; 95(1):29-39. DOI: 10.1016/s0092-8674(00)81780-8. View

11.

Brady-Kalnay S, Rimm D, Tonks N . Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo. J Cell Biol. 1995; 130(4):977-86. PMC: 2199947. DOI: 10.1083/jcb.130.4.977. View

12.

Blanquart C, Karouri S, Issad T . Protein tyrosine phosphatase-1B and T-cell protein tyrosine phosphatase regulate IGF-2-induced MCF-7 cell migration. Biochem Biophys Res Commun. 2010; 392(1):83-8. DOI: 10.1016/j.bbrc.2009.12.176. View

13.

Ruivenkamp C, Hermsen M, Postma C, Klous A, Baak J, Meijer G . LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene. 2003; 22(22):3472-4. DOI: 10.1038/sj.onc.1206246. View

14.

Halle M, Tremblay M, Meng T . Protein tyrosine phosphatases: emerging regulators of apoptosis. Cell Cycle. 2007; 6(22):2773-81. DOI: 10.4161/cc.6.22.4926. View

15.

Liu P, Wilson M . miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells. J Cell Physiol. 2011; 227(2):867-76. PMC: 3225649. DOI: 10.1002/jcp.22993. View

16.

Gu F, Nguyen D, Stuible M, Dube N, Tremblay M, Chevet E . Protein-tyrosine phosphatase 1B potentiates IRE1 signaling during endoplasmic reticulum stress. J Biol Chem. 2004; 279(48):49689-93. DOI: 10.1074/jbc.C400261200. View

17.

Iuliano R, Le Pera I, Cristofaro C, Baudi F, Arturi F, Pallante P . The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis. Oncogene. 2004; 23(52):8432-8. DOI: 10.1038/sj.onc.1207766. View

18.

Jiang W, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel R . Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer. 2004; 11(4):781-91. DOI: 10.1677/erc.1.00825. View

19.

Tiganis T, Kemp B, Tonks N . The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling. J Biol Chem. 1999; 274(39):27768-75. DOI: 10.1074/jbc.274.39.27768. View

20.

Zheng J, Kulp S, Zhang Y, Sugimoto Y, Dayton M, Govindan M . 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Anticancer Res. 2000; 20(1A):11-9. View